Most Active InvestorsFind investorsPricing
Start for free
Start for free
OM

Opaleye Management

North America, Massachusetts, United States, Boston

Description

Opaleye Management is an investment Firm.

Investor Profile

Opaleye Management has backed more than 10 startups, with 1 new investments in the last 12 months alone. The firm has led 1 rounds, about 10% of its total and boasts 6 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity, Series D, Series C rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Medical Device.

Stage Focus

  • Post Ipo Equity (50%)
  • Series D (10%)
  • Series C (10%)
  • Series B (10%)
  • Series A (10%)
  • Seed (10%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical Device
  • Health Diagnostics
  • Manufacturing
  • Therapeutics
  • Medical
  • Biopharma
  • Life Science
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Opaleye Management frequently co-invest with?

OrbiMed
OrbiMed
North America, New York, United States, New York
Co-Investments: 1
Pura Vida Investments
Pura Vida Investments
North America, New York, United States, New York
Co-Investments: 1
Surveyor Capital
Surveyor Capital
North America, Illinois, United States, Chicago
Co-Investments: 2
Samsara BioCapital
Samsara BioCapital
North America, California, United States, Palo Alto
Co-Investments: 2
Advent Venture Partners
Advent Venture Partners
Europe, England, United Kingdom, London
Co-Investments: 1
8VC
8VC
North America, California, United States, San Francisco
Co-Investments: 1
GE Ventures
GE Ventures
North America, California, United States, Menlo Park
Co-Investments: 1
Xeraya Capital
Xeraya Capital
Asia, Kuala Lumpur, Malaysia, Kuala Lumpur
Co-Investments: 1
Perceptive Advisors
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 2
Deerfield Capital Management
Deerfield Capital Management
North America, Illinois, United States, Rosamond
Co-Investments: 1

Which angels does Opaleye Management often collaborate with?

PS
Patrick Spaulding Ryan
North America, California, United States, San Mateo
Shared Deals: 1

What are some of recent deals done by Opaleye Management?

SANUWAVE Health

Alpharetta, Georgia, United States

SANUWAVE Health develops a shock wave technology used in devices for the repair and regeneration of bones, muscles, tendons, and skin.

BiotechnologyHealth CareHealth DiagnosticsManufacturingMedical Device
Post Ipo EquityOct 18, 2024
Amount Raised: $10,300,000
CARGO Therapeutics

San Mateo, California, United States

CARGO Therapeutics develops an adoptive cell therapy to benefit patients from potentially curative treatment options.

BiotechnologyMedicalTherapeutics
Post Ipo EquityMay 28, 2024
Amount Raised: $110,000,000
Ocular Therapeutix

Bedford, Massachusetts, United States

Ocular Therapeutix develops and commercializes ophthalmic therapeutic products by using hydrogel technology.

BiotechnologyHealth CareMedical Device
Post Ipo EquityFeb 22, 2024
Amount Raised: $325,000,000
IpiNovyx Bio

West Nyack, New York, United States

IpiNovyx Bio is a biopharmaceutical company developing immunoproteasome-modulating therapeutics to treat autoimmune diseases.

BiopharmaBiotechnologyHealth CareMedical
SeedOct 5, 2021
Amount Raised: $10,000,000
Tesseract Health

Guilford, Connecticut, United States

Tesseract Health provides devices for disease monitoring and prevention.

Health Care
Series BApr 20, 2021
Amount Raised: $80,000,000
ValenzaBio

Bethesda, Maryland, United States

ValenzaBio is developing safe and effective treatment options for patients with autoimmune and inflammatory diseases.

BiopharmaBiotechnologyHealth CarePharmaceutical
Series AApr 8, 2021
Amount Raised: $79,374,978
Palvella Therapeutics

Wayne, Pennsylvania, United States

Palvella Therapeutics focuses on relentlessly and selflessly serving abandoned patient populations with therapies.

BiotechnologyHealth CareLife ScienceTherapeutics
Series CMay 28, 2020
Amount Raised: $45,000,000
Stereotaxis

St Louis, Missouri, United States

Stereotaxis develops robotic cardiology instrument navigation systems that enhances the treatment of arrhythmias and coronary diseases.

BiotechnologyHealth CareMedical DeviceNavigation
Post Ipo EquityAug 8, 2019
Amount Raised: $25,000,000
Acutus Medical

Carlsbad, California, United States

Acutus Medical develops medical technologies to treat complex cardiac arrhythmia.

BiotechnologyHealth CareHealth DiagnosticsManufacturingMedical Device
Series DJun 20, 2019
Amount Raised: $100,000,000
Ekso Bionics

Richmond, California, United States

Ekso Bionics develops wearable exoskeletons for military, civilian and medical uses that augment strength, endurance and mobility.

Medical DeviceRoboticsWearables
Post Ipo EquityFeb 6, 2014
Amount Raised: $30,300,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Most Active Investors Find InvestorsNewsletterPricing

Free tools

Pre-Money and Post-Money Valuation Calculator